|
1 |
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Enthalten in Seminars in thrombosis and hemostasis 01.03.2024
|
|
|
2 |
Usefulness of Rivaroxaban for secondary prevention of acute coronary syndrome in patients with history of congestive heart failure (from the ATLAS-ACS-2 TIMI-51 trial)
Korjian, Serge. - Freiburg : Universität, 2023
|
|
|
|
3 |
Interleukin‐6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID‐TIMI 52 (stabilization of plaque using Darapladib-Thrombolysis in myocardial infarction 52) trial
Fanola, Christina L.. - Freiburg : Universität, 2019
|
|
|
|
4 |
Adult Congenital Heart Disease
New York, NY : John Wiley & Sons, 2008
|
|
|
5 |
Optimal strategies in preventing the next event: the role of statins in cardiovascular protection
Amsterdam : Elsevier, 2003
|
|
|
|
6 |
Instabile Angina pectoris
München : Arcis-Verl., 1997
|
|
|
|
7 |
Ventrikelentlastung nach Herzinfarkt: die Bedeutung der ACE-Hemmer
Erlangen : perimed-Verl., 1991
|
|
|
|
8 |
Prinzipien der inneren Medizin / Bd. 1. Vollständige Übersetzung der 11. Auflage von "Harrison's principles of internal medicine"
1989, [2. dt. Aufl.]
|
|
|
|
9 |
Prinzipien der inneren Medizin / Bd. 2. Vollständige Übersetzung der 11. Auflage von "Harrison's principles of internal medicine"
1989, [2. dt. Aufl.]
|
|
|
|
10 |
Perspectives on Treatment of Acute Pulmonary Embolism with Tissue Plasminogen Activator
Enthalten in Seminars in thrombosis and hemostasis Bd. 13, 1987, Nr. 02: 171-177
|
|
Administration
